Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00792727 · ClinicalTrials.gov registry record · Phase 3
HKT-500 in Adult Patients With Osteoarthritis (OA) Knee Pain
A Phase 3 study, sponsored by Hisamitsu Pharmaceutical Co..
- Completed
- Registry status
- Phase 3
- Development phase
- 380
- Enrollment target
NCT00792727 is a Phase 3 study that has completed, run by Hisamitsu Pharmaceutical Co.. The registered enrollment target is 380 participants.
The verdict
NCT00792727, a Phase 3 study, has completed, sponsored by Hisamitsu Pharmaceutical Co..
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 380 participants
- Enrollment target
Study Summary
Ketoprofen in a topical patch formulation has been demonstrated to be effective for treating mild to moderate pain caused by various musculoskeletal disorders.
Interventions
- OTHER Placebo Patch
- DRUG ketoprofen Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 380 participants |
| Start Date | 2007-09 |
| Est. Completion | 2008-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00792727
The ClinicalTrials.gov registry entry for NCT00792727 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 380 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hisamitsu Pharmaceutical Co., which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Patch is the first listed.
NCT00792727 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00792727 about?
NCT00792727 is a clinical study titled "HKT-500 in Adult Patients With Osteoarthritis (OA) Knee Pain". Ketoprofen in a topical patch formulation has been demonstrated to be effective for treating mild to moderate pain caused by various musculoskeletal disorders.
What is the current status of trial NCT00792727?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 380 participants. The study started on 2007-09. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00792727?
The interventions under investigation include: Placebo Patch (OTHER), ketoprofen Patch (DRUG).
Who is sponsoring clinical trial NCT00792727?
This trial is sponsored by Hisamitsu Pharmaceutical Co., which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.